Biotech and Pharma M&A in 2020

Biotech and Pharma M&A in 2020

Analysis | M&A Biotech and Pharma M&A in 2020 Biotech and pharma M&A total deal values slumped in 2020, despite an active year in life sciences dealmaking, with no big standout biopharma deals until late in the second half of the year. It could also be...
Life Sciences M&A Tops $240 Billion in 2019

Life Sciences M&A Tops $240 Billion in 2019

Analysis | M&A Life Sciences M&A Tops $240 Billion in 2019 This article is a sample from the DealForma Annual Deal Trends Report provided to database subscribers. Data for this analysis was compiled using the DealForma biopharma deals database. We applied...
Top Investors in Biotech Venture Rounds

Top Investors in Biotech Venture Rounds

Analysis | Funding Top Investors in Biotech Venture Rounds Data for the this analysis was compiled using the DealForma database; specifically the companies and venture funding sections. We used company location data tagged with the three major U.S. biotech hubs along...